Trial
NCT03796156
Aspirin to Target Arterial Events in Chronic Kidney Disease
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Southampton
Collaborators
University of Nottingham; University of Warwick; Nottingham University Hospitals NHS Trust; East Kent Hospitals University NHS Foundation Trust; University of Durham; Epsom and St Helier University Hospitals NHS Trust
Condition
Chronic Kidney Diseases
Intervention
Aspirin
Why stopped
Planned recruitment total was not achievable within the funded timeframe
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-20